These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Edelstein PH, Edelstein MA. Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571 [Abstract] [Full Text] [Related]
6. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Edelstein PH, Shinzato T, Edelstein MA. J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556 [Abstract] [Full Text] [Related]
13. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia. Edelstein PH, Weiss WJ, Edelstein MA. Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655 [Abstract] [Full Text] [Related]
14. In vitro and in vivo activities of sparfloxacin in Legionella infections. Saito A, Gaja M. Drugs; 1995 Feb; 49 Suppl 2():250-2. PubMed ID: 8549320 [No Abstract] [Full Text] [Related]
15. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells. Stout JE, Arnold B, Yu VL. Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830 [Abstract] [Full Text] [Related]
16. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease. Kohno S, Koga H, Yamaguchi K, Masaki M, Inoue Y, Dotsu Y, Masuyama Y, Hayashi T, Hirota M, Saito A. J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201 [Abstract] [Full Text] [Related]
17. Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages. Walz A, Nichterlein T, Hof H. Zentralbl Bakteriol; 1997 Feb; 285(3):431-9. PubMed ID: 9084116 [Abstract] [Full Text] [Related]
18. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. Baltch AL, Bopp LH, Smith RP, Michelsen PB, Ritz WJ. J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776 [Abstract] [Full Text] [Related]
19. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH, Edelstein MA, Holzknecht B. Antimicrob Agents Chemother; 1992 Nov; 36(11):2387-91. PubMed ID: 1489182 [Abstract] [Full Text] [Related]
20. In vitro and in vivo efficacy of fusafungine on Legionella pneumophila. Pocidalo JJ, Assous M. Rhinol Suppl; 1988 Nov; 5():45-53. PubMed ID: 3244983 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]